Back to today’s briefing

Story perspectives

AI Access Decisions: Key to Future Medical Innovation

1/30/2026

36 5 Full Breakdown

Summary

Story summary

AI access decisions will shape decades of medical innovation.
Recursion and Absci thrive, while many smaller biotechs struggle due to high costs and limited access to advanced infrastructure.
Systemic barriers, such as data monopolies and regulatory complexities, favor larger firms.
Policymakers and industry leaders must treat AI infrastructure as essential research equipment to ensure equitable access and enable collaborative ecosystems.

1 of 1

Story summary

AI access decisions will shape decades of medical innovation.
Recursion and Absci thrive, while many smaller biotechs struggle due to high costs and limited access to advanced infrastructure.
Systemic barriers, such as data monopolies and regulatory complexities, favor larger firms.
Policymakers and industry leaders must treat AI infrastructure as essential research equipment to ensure equitable access and enable collaborative ecosystems.